{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:24:55Z","timestamp":1761222295628,"version":"build-2065373602"},"reference-count":30,"publisher":"Danish Medical Association","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ugeskr L\u00e6ger"],"abstract":"<jats:p>During the last ten years, there has been generated a lot of insights in the mechanisms and pathophysiology behind chronic cough. In some countries, tertiary cough clinics have been established, but not in Denmark. This review finds it is important to have a diagnostic workup that is in balance with the national healthcare system. The neuroplasticity of the brain may enhance cough and cause the cough hypersensitivity syndrome. The development of drugs targeting the P2X3 receptor will hopefully introduce a new era in the treatment of chronic cough.<\/jats:p>","DOI":"10.61409\/v02240104","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T11:31:12Z","timestamp":1760009472000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["New options in the treatment of chronic cough"],"prefix":"10.61409","author":[{"given":"Ole","family":"Hilberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Wolsing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders L\u00f8kke","family":"Ottesen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"40208","published-online":{"date-parts":[[2025,10,6]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Campi G, Noale M, Fabbrizzi A et al. The demographic and clinical characteristics of an Italian population of adult outpatients with chronic cough. Aging Clin Exp Res. 2020;32(4):741-746. https:\/\/doi.org\/10.1007\/s40520-019-01464-4","DOI":"10.1007\/s40520-019-01464-4"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Satia I, Mayhew AJ, Sohel N et al. Prevalence, incidence and characteristics of chronic cough among adults from the Canadian Longitudinal Study on Aging. ERJ Open Res. 2021;7(2):00160-2021. https:\/\/doi.org\/10.1183\/23120541.00160-2021","DOI":"10.1183\/23120541.00160-2021"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Song WJ, Chang YS, Faruqi S et al. The global epidemiology of chronic cough in adults: a systematic review and meta-analysis. Eur Respir J. 2015;45(5):1479-81. https:\/\/doi.org\/10.1183\/09031936.00218714","DOI":"10.1183\/09031936.00218714"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Kang SY, Kim GW, Song WJ et al. Chronic cough in Korean adults: a literature review on common comorbidity. Asia Pac Allergy. 2016;6(4):198-206. https:\/\/doi.org\/10.5415\/apallergy.2016.6.4.198","DOI":"10.5415\/apallergy.2016.6.4.198"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Chung KF, McGarvey L, Song WJ et al. Cough hypersensitivity and chronic cough. Nat Rev Dis Primers. 2022;8(1):45. https:\/\/doi.org\/10.1038\/s41572-022-00370-w","DOI":"10.1038\/s41572-022-00370-w"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"\u00c7olak Y, Nordestgaard BG, Laursen LC et al. Risk factors for chronic cough among 14,669 individuals from the general population. Chest. 2017;152(3):563-573. https:\/\/doi.org\/10.1016\/j.chest.2017.05.038","DOI":"10.1016\/j.chest.2017.05.038"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Virchow JC, Li VW, Fonseca E et al. Chronic cough in Germany: results from a general-population survey. ERJ Open Res. 2022;8(1):00420-2021. https:\/\/doi.org\/10.1183\/23120541.00420-2021","DOI":"10.1183\/23120541.00420-2021"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Backer V, Porsborg A, Hansen V et al. A register-based study: cough - a frequent phenomenon in the adult population. BMC Pulm Med. 2022;22(1):426. https:\/\/doi.org\/10.1186\/s12890-022-02228-z","DOI":"10.1186\/s12890-022-02228-z"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Arinze JT, van der Veer T, Bos D et al. Epidemiology of unexplained chronic cough in adults: a population-based study. ERJ Open Res. 2023;9(3):00739-2022. https:\/\/doi.org\/10.1183\/23120541.00739-2022","DOI":"10.1183\/23120541.00739-2022"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Cui WW, Wang SY, Zhang YQ et al. P2X3-selective mechanism of gefapixant, a drug candidate for the treatment of refractory chronic cough. Comput Struct Biotechnol J. 2022;20:1642-1653. https:\/\/doi.org\/10.1016\/j.csbj.2022.03.030","DOI":"10.1016\/j.csbj.2022.03.030"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Rouadi PW, Idriss SA, Bousquet J et al. WAO-ARIA consensus on chronic cough - Part 1: role of TRP channels in neurogenic inflammation of cough neuronal pathways. World Allergy Organ J. 2021;14(12):100617. https:\/\/doi.org\/10.1016\/j.waojou.2021.100617","DOI":"10.1016\/j.waojou.2021.100617"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"McGarvey LP, Birring SS, Morice AH et al. Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials. Lancet. 2022;399(10328):909-923. https:\/\/doi.org\/10.1016\/S0140-6736(21)02348-5","DOI":"10.1016\/S0140-6736(21)02348-5"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"High B, Jett\u00e9 ME, Li M et al. Variability in P2X receptor composition in human taste nerves: implications for treatment of chronic cough. ERJ Open Res. 2023;9(2):00007-2023. https:\/\/doi.org\/10.1183\/23120541.00007-2023","DOI":"10.1183\/23120541.00007-2023"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Ghouse J, Tragante V, Muhammad A et al. Polygenic risk score for ACE-inhibitor-associated cough based on the discovery of new genetic loci. Eur Heart J. 2022;43(45):4707-4718. https:\/\/doi.org\/10.1093\/eurheartj\/ehac322","DOI":"10.1093\/eurheartj\/ehac322"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Kim TB, Oh SY, Park HK et al. Polymorphisms in the neurokinin-2 receptor gene are associated with angiotensin-converting enzyme inhibitor-induced cough. J Clin Pharm Ther. 2009;34(4):457-64. https:\/\/doi.org\/10.1111\/j.1365-2710.2008.01018.x","DOI":"10.1111\/j.1365-2710.2008.01018.x"},{"key":"ref15","unstructured":"Singh DP, Jamil RT, Mahajan K. Nocturnal cough. I: StatPearls. StatPearls Publishing, 2023. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532273\/"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Morice A, Dicpinigaitis P, McGarvey L, Birring SS. Chronic cough: new insights and future prospects. Eur Respir Rev. 2021;30(162):210127. https:\/\/doi.org\/10.1183\/16000617.0127-2021","DOI":"10.1183\/16000617.0127-2021"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Ding H, Shi C, Xu X, Yu L. Drug-induced chronic cough and the possible mechanism of action. Ann Palliat Med. 2020;9(5):3562-3570. https:\/\/doi.org\/10.21037\/apm-20-819","DOI":"10.21037\/apm-20-819"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Kirschen GW, Kirschen H, Gabalski E et al. Successful use of guanfacine in a patient with chronic refractory cough: a case report. Respir Med Case Rep. 2017;22:268-270. https:\/\/doi.org\/10.1016\/j.rmcr.2017.10.001","DOI":"10.1016\/j.rmcr.2017.10.001"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Chung KF. Chronic 'cough hypersensitivity syndrome': a more precise label for chronic cough. Pulm Pharmacol Ther. 2011;24(3):267-71. https:\/\/doi.org\/10.1016\/j.pupt.2011.01.012","DOI":"10.1016\/j.pupt.2011.01.012"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Faruqi S, Murdoch R, Allum F, Morice AH. On the definition of chronic cough and current treatment pathways: an international qualitative study. Cough. 2014;10(1):5. https:\/\/doi.org\/10.1186\/1745-9974-10-5","DOI":"10.1186\/1745-9974-10-5"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Irwin RS, French CL, Chang AB et al. Classification of cough as a symptom in adults and management algorithms: CHEST guideline and expert panel report. Chest. 2018;153(1):196-209. https:\/\/doi.org\/10.1016\/j.chest.2017.10.016","DOI":"10.1016\/j.chest.2017.10.016"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Song WJ, Dupont L, Birring SS et al. Consensus goals and standards for specialist cough clinics: the NEUROCOUGH international Delphi study. ERJ Open Res. 2023;9(6):00618-2023. https:\/\/doi.org\/10.1183\/23120541.00618-2023","DOI":"10.1183\/23120541.00618-2023"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Klitgaard A, L\u00f8kke A, Fr\u00f8lund J et al. Introduction of a systematic examination framework for chronic cough: a before-after cohort study in a clinical setting. Eur Clin Respir J. 2023;10(1):2273026. https:\/\/doi.org\/10.1080\/20018525.2023.2273026","DOI":"10.1080\/20018525.2023.2273026"},{"key":"ref24","unstructured":"\u00c7olak Y, Laursen LC. Udredning og behandling af hoste. Ugeskr L\u00e6ger. 2013;175(7):418-424. https:\/\/ugeskriftet.dk\/videnskab\/udredning-og-behandling-af-hoste"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Morice AH, Millqvist E, Bieksiene K et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136. https:\/\/doi.org\/10.1183\/13993003.01136-2019","DOI":"10.1183\/13993003.01136-2019"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Li W, Zhang T, Gu W et al. A comparison between a gastroesophageal reflux disease questionnaire-based algorithm and multichannel intraluminal impedance-pH monitoring for the treatment of gastroesophageal reflux-induced chronic cough. Ther Adv Respir Dis. 2024;18:17534666231220817. https:\/\/doi.org\/10.1177\/17534666231220817","DOI":"10.1177\/17534666231220817"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Fraser SD, Thackray-Nocera S, Shepherd M et al. Azithromycin for sarcoidosis cough: an open-label exploratory clinical trial. ERJ Open Res. 2020;6(4):00534-2020. https:\/\/doi.org\/10.1183\/23120541.00534-2020","DOI":"10.1183\/23120541.00534-2020"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Martin MJ, Lee H, Clayton C et al. Idiopathic chronic productive cough and response to open-label macrolide therapy: an observational study. Respirology. 2019;24(6):558-565. https:\/\/doi.org\/10.1111\/resp.13483","DOI":"10.1111\/resp.13483"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: a randomised, double-blind, placebo-controlled trial. Lancet. 2012;380(9853):1583-9. https:\/\/doi.org\/10.1016\/S0140-6736(12)60776-4","DOI":"10.1016\/S0140-6736(12)60776-4"}],"container-title":["Ugeskrift for L\u00e6ger"],"original-title":[],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:50:47Z","timestamp":1761220247000},"score":1,"resource":{"primary":{"URL":"https:\/\/ugeskriftet.dk\/videnskab\/V02240104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,6]]},"references-count":30,"URL":"https:\/\/doi.org\/10.61409\/v02240104","relation":{},"ISSN":["0041-5782","1603-6824"],"issn-type":[{"type":"print","value":"0041-5782"},{"type":"electronic","value":"1603-6824"}],"subject":[],"published":{"date-parts":[[2025,10,6]]}}}